Journal article icon

Journal article

Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?

Abstract:

Chronic lymphocytic leukemia (CLL) is low-grade lymphoma of mature B cells and it is considered to be the most common type of hematological malignancy in the western world. CLL is characterized by a chronically relapsing course and clinical and biological heterogeneity. Many patients do not require any treatment for years. Although important progress has been made in the treatment of CLL, none of the conventional treatment options are curative. Recurrent chromosomal abnormalities have been id...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2217/pme.13.33

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, WTC Human Genetics
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Oncology
Role:
Author
Journal:
Personalized medicine
Volume:
10
Issue:
4
Pages:
361-376
Publication date:
2013-06-05
DOI:
EISSN:
1744-828X
ISSN:
1741-0541
URN:
uuid:ac319b08-43c6-4b55-b83d-52e1e31115c3
Source identifiers:
409903
Local pid:
pubs:409903

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP